Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for sleep quality in adults with moderate to severe atopic dermatitis
2018-004705-26Phase 4Unknown
- Sponsor
- Sanofi
- Start
- Aug 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Dupilumab with Placebo (2 arms). Primary endpoint: Percentage change from baseline to Week 12 in sleep quality numerical rating scale. Status: unknown.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2018-004705-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004705-26.